Evaluating dysphagia and xerostomia outcomes following transoral robotic surgery for patients with oropharyngeal cancer
| Autor: | Urjeet A. Patel, Rebecca Prince, Brittni N. Carnes, Katelyn O. Stepan, Mitesh P. Mehta, Sandeep Samant, Bharat B. Mittal, Bryce E. Maxwell, Zeeshan Butt |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Adjuvant radiotherapy business.industry Oropharyngeal surgery Cancer Survey research medicine.disease Dysphagia Gastroenterology Xerostomia Oropharyngeal Neoplasms Cross-Sectional Studies Otorhinolaryngology Robotic Surgical Procedures Internal medicine Transoral robotic surgery Adjuvant therapy Medicine Humans medicine.symptom business Deglutition Disorders Adjuvant chemoradiotherapy |
| Zdroj: | HeadneckREFERENCES. 43(12) |
| ISSN: | 1097-0347 |
| Popis: | BACKGROUND We assessed long-term patient-reported dysphagia and xerostomia outcomes following definitive surgical management with transoral robotic surgery (TORS) in patients with oropharyngeal cancer (OPC) via a cross-sectional survey study. METHODS Patients with OPC managed with primary oropharyngeal surgery as definitive treatment at least 1 year ago between 2015 and 2019 were identified. The M. D. Anderson Dysphagia Inventory (MDADI) and Xerostomia Inventory (XI) scores were compared across treatment types (i.e., no adjuvant therapy [TORS-A] vs. adjuvant radiotherapy [TORS+RT] vs. adjuvant chemoradiotherapy [TORS+CT/RT]). RESULTS The sample had 62 patients (10 TORS-A, 30 TORS+RT, 22 TORS+CT/RT). TORS-A had clinically and statistically significantly better MDADI scores than TORS+RT (p = 0.03) and TORS+CT/RT (p = 0.02), but TORS+RT and TORS+CT/RT were not significantly different. TORS-A had clinically and statistically significantly less XI than TORS+RT (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text